Gene chips bring new order to lung cancer types, could yield sharper diagnoses, better drugs
Using miniaturized chips that make snapshots of the activity of thousands of genes at once, Dana-Farber Cancer Institute scientists have divided lung cancers into new categories based on their gene functions rather than the cells’ appearance under a microscope. The researchers say it’s a first step toward a more useful classification of lung cancers that could yield sharper diagnoses and better treatments for the number one cancer killer.
NIH/National Cancer Institute, Millennium Pharmaceuticals, Affymetrix, Bristol-Myers Squibb
Dana-Farber Cancer Institute
Message posted by: Wouter Kalle